ES8502992A1 - Ergot alkaloids - Google Patents

Ergot alkaloids

Info

Publication number
ES8502992A1
ES8502992A1 ES524815A ES524815A ES8502992A1 ES 8502992 A1 ES8502992 A1 ES 8502992A1 ES 524815 A ES524815 A ES 524815A ES 524815 A ES524815 A ES 524815A ES 8502992 A1 ES8502992 A1 ES 8502992A1
Authority
ES
Spain
Prior art keywords
alkyl
agents
ergot alkaloids
phenyl
lysergyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES524815A
Other languages
Spanish (es)
Other versions
ES524815A0 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of ES8502992A1 publication Critical patent/ES8502992A1/en
Publication of ES524815A0 publication Critical patent/ES524815A0/en
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D457/00Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

2-methyl-lysergyl ethers and thioethers are useful neuroleptics, anti-migraine agents, cerebral insufficiency agents, agents for senile dementia and anti-depressants. Preferably compounds of formula < IMAGE > where X is O or S, R1 is H, C1-4 alkyl or phenyl, R2 is C1-3 alkyl and R3 is phenyl or pyridyl, which may be substituted, or alkyl are used.
ES524815A 1982-08-09 1983-08-08 PROCEDURE FOR THE PREPARATION OF A (TIO) -ETER OF 2-METHYL-LISERG-8-ILO Granted ES524815A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH4772/82A CH649998A5 (en) 1982-08-09 1982-08-09 ERGOL DERIVATIVES, A METHOD FOR THEIR PRODUCTION AND HEALING AGENTS, CONTAINING THESE ERGOL DERIVATIVES AS AN ACTIVE SUBSTANCE.

Publications (2)

Publication Number Publication Date
ES8502992A1 true ES8502992A1 (en) 1985-02-01
ES524815A0 ES524815A0 (en) 1985-02-01

Family

ID=4282273

Family Applications (1)

Application Number Title Priority Date Filing Date
ES524815A Granted ES524815A0 (en) 1982-08-09 1983-08-08 PROCEDURE FOR THE PREPARATION OF A (TIO) -ETER OF 2-METHYL-LISERG-8-ILO

Country Status (23)

Country Link
JP (1) JPS5948480A (en)
AT (1) AT383125B (en)
AU (1) AU563736B2 (en)
BE (1) BE897473A (en)
CA (1) CA1215972A (en)
CH (1) CH649998A5 (en)
DE (1) DE3327705A1 (en)
DK (1) DK361983A (en)
ES (1) ES524815A0 (en)
FI (1) FI73679C (en)
FR (1) FR2531433B1 (en)
GB (1) GB2125041B (en)
GR (1) GR78923B (en)
HU (1) HU187600B (en)
IL (1) IL69450A (en)
IT (1) IT1168961B (en)
MY (1) MY8700166A (en)
NL (1) NL8302776A (en)
NZ (1) NZ205181A (en)
PH (1) PH20385A (en)
PT (1) PT77168B (en)
SE (1) SE8304315L (en)
ZA (1) ZA835850B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675322A (en) * 1984-12-10 1987-06-23 Eli Lilly And Company 1-Substituted-6-n-propyl-8β-methylthio-methylergolines
HU193782B (en) * 1985-06-21 1987-11-30 Richter Gedeon Vegyeszet Process for producing 2-halogeno-nicergoline derivatives and acid additional salts thereof
FR2589734B1 (en) * 1985-11-13 1988-09-02 Roussel Uclaf USE OF ERGOLIN DERIVATIVES FOR OBTAINING A GERIATRIC MEDICINE
US4798834A (en) * 1987-08-31 1989-01-17 Eli Lilly And Company Optionally substituted (3β-9,10-didehydro-2,3-dihydro ergoline as serotonergic function enhancement
DE3913756A1 (en) * 1989-04-21 1990-10-25 Schering Ag 8 (BETA) SUBSTITUTED ERGOLINE, METHOD FOR THE PRODUCTION AND USE THEREOF
DE10212564B4 (en) * 2002-03-12 2007-04-19 Neurobiotec Gmbh 1-Allyl ergot alkaloid derivatives and their use for the prophylaxis and treatment of migraine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE41533B1 (en) * 1974-03-14 1980-01-30 Sandoz Ltd Thiomethyl ergolene derivatives
US3901894A (en) * 1974-06-06 1975-08-26 Lilly Co Eli 8-thiomethylergolines
US3959288A (en) * 1974-12-13 1976-05-25 Eli Lilly And Company 8-Oxymethylergolines and process therefor
US4166182A (en) * 1978-02-08 1979-08-28 Eli Lilly And Company 6-n-propyl-8-methoxymethyl or methylmercaptomethylergolines and related compounds
US4382940A (en) * 1979-12-06 1983-05-10 Farmitalia Carlo Erba S.P.A. Ercoline derivatives and therapeutic compositions having CNS affecting activity

Also Published As

Publication number Publication date
ZA835850B (en) 1985-03-27
CA1215972A (en) 1986-12-30
JPS5948480A (en) 1984-03-19
AT383125B (en) 1987-05-25
FI832789A0 (en) 1983-08-02
GB2125041A (en) 1984-02-29
FR2531433B1 (en) 1985-10-18
IL69450A (en) 1986-10-31
HU187600B (en) 1986-01-28
SE8304315D0 (en) 1983-08-08
AU1767283A (en) 1984-02-16
PH20385A (en) 1986-12-08
IT8322490A0 (en) 1983-08-09
DE3327705A1 (en) 1984-02-09
PT77168B (en) 1986-03-27
CH649998A5 (en) 1985-06-28
BE897473A (en) 1984-02-06
GB8321222D0 (en) 1983-09-07
MY8700166A (en) 1987-12-31
DK361983A (en) 1984-02-10
IL69450A0 (en) 1983-11-30
FR2531433A1 (en) 1984-02-10
ATA286383A (en) 1986-10-15
ES524815A0 (en) 1985-02-01
AU563736B2 (en) 1987-07-23
SE8304315L (en) 1984-02-10
FI73679C (en) 1987-11-09
FI73679B (en) 1987-07-31
GB2125041B (en) 1986-04-23
NZ205181A (en) 1986-07-11
DK361983D0 (en) 1983-08-08
FI832789A (en) 1984-02-10
GR78923B (en) 1984-10-02
NL8302776A (en) 1984-03-01
IT1168961B (en) 1987-05-20
PT77168A (en) 1983-09-01

Similar Documents

Publication Publication Date Title
DE3379222D1 (en) Intermediates for the preparation of omeprazole
ES8802497A1 (en) 1.4-dihydro pyridines
AU575797B2 (en) Azanapthalene derivatives
EP0224163A3 (en) Propyl amines, process for their preparation and their use as fungicides
ES8502992A1 (en) Ergot alkaloids
PT76998A (en) Process for preparing novel heterocyclic substituted compounds of sulphonylurea and herbicidal compositions containing them
AU1395283A (en) 1-carboxyalkanoylindoline-2-carboxylic acid esters
ES8707508A1 (en) Triazinylaminobenzaldehydes
ES2000292A6 (en) Condensed triazolo compounds.
LV10234B (en) Method of preparation of triodobenzene compoundsss for preparing same
EP0108547A3 (en) 1-bromoethyl ethyl carbonate and its use in the preparation of 1&#39;-ethoxy-carbonyloxyethyl esters of penicillins and novel intermediates, methods for its preparation and 1-bromoethylchloroformate and 1-bromoethylbromoformate obtained as intermediates
DE3165118D1 (en) Vinyl-3 cephalosporin derivatives and their preparation
ES8600251A1 (en) 5-Phenylethenylbenzimidazoles.
ES8103092A1 (en) Clavulanic acid derivatives, preparation and compositions.
ES8502444A1 (en) Process for the preparation of cephem compounds
GR76302B (en)
YU216483A (en) Process for preparing new semicarbazides